New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - sodium iotalamate 54% - solution for injection - 54 % - active: sodium iotalamate 54%

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - sodium iotalamate 70% - solution for injection - 70 % - active: sodium iotalamate 70%

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - phenol 120 mg/ml; sodium iotalamate 700 mg/ml - solution for injection - 12%/70% - active: phenol 120 mg/ml sodium iotalamate 700 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - meglumine iotalamate 52%; sodium iotalamate 26% - solution for injection - 52%/26% - active: meglumine iotalamate 52% sodium iotalamate 26%

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

iodine 280mg/ml) / phenol 60mg/ml solution for injection 5ml ampoules (special order - phenol; meglumine iotalamate - solution for injection - 60mg/1ml ; 600mg/1ml

Ireland - English - HPRA (Health Products Regulatory Authority)

mallinckrodt uk commercial ltd - iotalamate meglumine - solution for injection - 14/50 micromol

Ireland - English - HPRA (Health Products Regulatory Authority)

may & baker limited - iotalamate sodium - solution for injection - 325 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

may & baker limited - iotalamate sodium - solution for injection - 325 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

mallinckrodt uk limited - iotalamate sodium - solution for injection - 325 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

mallinckrodt uk limited - iotalamate sodium - solution for injection - 50 millilitre